109451
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
基于非靶向代谢组学的人乳头瘤病毒感染与宫颈癌差异代谢物的研究
Authors Xu J, Wang M, Jia Y, Chen Y, Duan Y, Ni M, Wang Y, Wei J, Yu J
Received 18 February 2025
Accepted for publication 17 October 2025
Published 30 October 2025 Volume 2025:17 Pages 3995—4009
DOI https://doi.org/10.2147/IJWH.S523559
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Elie Al-Chaer
Jinmei Xu, Ming Wang, Yue Jia, Yanfen Chen, Yangjuan Duan, Mengting Ni, Yinghai Wang, Jie Wei, Jing Yu
Department of Gynecology, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospital Yunnan, Kunming, Yunnan, 650118, People’s Republic of China
Correspondence: Jing Yu, Email 774878940@qq.com
Objective: To explore the difference of metabolites between human papillomavirus (HPV) infection and the occurrence and development of cervical cancer based on non-targeted metabolomics.
Methods: Between August 2022 and August 2023, 20 women of childbearing age at the Third Affiliated Hospital of Kunming Medical University, including the HPV-negative control, LSIL (HPV infection), HSIL (cervical intraepithelial neoplasia [CIN2-3]), and cervical cancer groups, were selected as research participants. Ultra-high-performance liquid chromatography and SCIEX mass spectrometry (TripleTOF 6600+, USA) were used to separate and detect the metabolites.
Results: According to the results of the differential metabolite analysis, the KEGG pathway was enriched. The most obvious enrichment pathway in the CIN2-3 group compared with the HPV-negative and HPV-positive groups was the steroid hormone pathway; the most obvious enrichment pathway in the cervical cancer group compared with the HPV-negative group was the steroid hormone pathway. Compared with HPV-negative group, the most obvious enrichment pathway in the CIN2-3 group was the glycerophosphate metabolism pathway. Compared with CIN2-3 and HPV-positive group, the most obvious enrichment pathway in the cervical cancer group was the sphingolipid metabolism pathway, followed by the steroid biosynthesis and amino sugar and nucleotide metabolism pathways. Compared with the HPV-negative group, the most obvious enrichment pathway in the cervical cancer group was the steroid biosynthesis pathway, followed by the sphingolipid metabolism pathway. 19-Hydroxytestosterone is involved in the synthesis of steroid hormones. Cerebroside B is involved in sphingolipid metabolism. Potassium acetate is involved in protein digestion and absorption. Methylarsonate is involved in chemical carcinogenesis - reactive oxygen species.
Conclusion: The expression levels of 19-Hydroxytestosterone, cerebroside B, potassium acetate and methylarsonate are downregulated with the aggravation of cervical lesions and can be used as potential tumor markers for cervical cancer.
Keywords: cervical cancer, non-targeted metabolomics, HPV
Department of Gynecology, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospital Yunnan, Kunming, Yunnan, 650118, People’s Republic of China
Correspondence: Jing Yu, Email 774878940@qq.com
Objective: To explore the difference of metabolites between human papillomavirus (HPV) infection and the occurrence and development of cervical cancer based on non-targeted metabolomics.
Methods: Between August 2022 and August 2023, 20 women of childbearing age at the Third Affiliated Hospital of Kunming Medical University, including the HPV-negative control, LSIL (HPV infection), HSIL (cervical intraepithelial neoplasia [CIN2-3]), and cervical cancer groups, were selected as research participants. Ultra-high-performance liquid chromatography and SCIEX mass spectrometry (TripleTOF 6600+, USA) were used to separate and detect the metabolites.
Results: According to the results of the differential metabolite analysis, the KEGG pathway was enriched. The most obvious enrichment pathway in the CIN2-3 group compared with the HPV-negative and HPV-positive groups was the steroid hormone pathway; the most obvious enrichment pathway in the cervical cancer group compared with the HPV-negative group was the steroid hormone pathway. Compared with HPV-negative group, the most obvious enrichment pathway in the CIN2-3 group was the glycerophosphate metabolism pathway. Compared with CIN2-3 and HPV-positive group, the most obvious enrichment pathway in the cervical cancer group was the sphingolipid metabolism pathway, followed by the steroid biosynthesis and amino sugar and nucleotide metabolism pathways. Compared with the HPV-negative group, the most obvious enrichment pathway in the cervical cancer group was the steroid biosynthesis pathway, followed by the sphingolipid metabolism pathway. 19-Hydroxytestosterone is involved in the synthesis of steroid hormones. Cerebroside B is involved in sphingolipid metabolism. Potassium acetate is involved in protein digestion and absorption. Methylarsonate is involved in chemical carcinogenesis - reactive oxygen species.
Conclusion: The expression levels of 19-Hydroxytestosterone, cerebroside B, potassium acetate and methylarsonate are downregulated with the aggravation of cervical lesions and can be used as potential tumor markers for cervical cancer.
Keywords: cervical cancer, non-targeted metabolomics, HPV